Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice
- 2 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Quality of Life Research
- Vol. 30 (11), 3255-3266
- https://doi.org/10.1007/s11136-020-02721-0
Abstract
Introduction Routine Electronic Monitoring of Health-Related Quality of Life (HRQoL) (REMOQOL) in clinical care with real-time feedback to physicians could help to enhance patient-centered care. We evaluated the feasibility of REMOQOL in the French context in the QOLIBRY study. The primary objective was to assess the patients’ compliance with REMOQOL. Methods The QOLIBRY study was a single-center, prospective study conducted in the University Hospital of Besançon (France). Eligible patients were those treated with systemic therapies for breast, lung or colorectal cancer at any stage. Patients were invited to complete the EORTC QLQ-C30 questionnaire and cancer-site-specific modules before each visit on tablets and/or computers in the hospital or at home. During the consultation, physicians had real-time access to visual summaries of HRQoL scores. Compliance was assessed as adequate if at least 66% of HRQoL assessments were completed during the 4 months of follow-up. Results Between March 2016 and October 2018, 177 patients were included in the QOLIBRY study. Median age was 64 years (IQR 54–71). The proportion of patients with an adequate compliance rate was 95.5% (n = 63) in the breast cancer cohort, 98.2% (n = 55) in the colorectal cancer cohort, and 90.9% (n = 50) in the lung cancer cohort. The physicians checked the HRQoL results in 73.1% of visits and prescribed supportive care and adapted patient management in 8.3% and 5.2% of visits, respectively. Conclusion & perspectives The results of QOLIBRY study suggest that REMOQOL is feasible in the French context. However, information about HRQoL monitoring, training of the physicians in the use of the software, and recommendations for using HRQoL results to guide care are essential and must be improved.Keywords
Funding Information
- Conseil régional de Bourgogne-Franche-Comté (APICHU 2016)
This publication has 40 references indexed in Scilit:
- Exploring the implementation of patient-reported outcome measures in cancer care: need for more real-world evidence results in the peer reviewed literatureJournal of Patient-Reported Outcomes, 2018
- Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communicationSupportive Care in Cancer, 2017
- Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standardsThe Lancet Oncology, 2016
- The use and impact of quality of life assessment tools in clinical care settings for cancer patients, with a particular emphasis on brain cancer: insights from a systematic review and stakeholder consultationsQuality of Life Research, 2016
- Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled TrialJournal of Clinical Oncology, 2016
- Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factorsAnnals of Oncology, 2015
- What Is the Value of the Routine Use of Patient-Reported Outcome Measures Toward Improvement of Patient Outcomes, Processes of Care, and Health Service Outcomes in Cancer Care? A Systematic Review of Controlled TrialsJournal of Clinical Oncology, 2014
- Electronic Self-Report Assessment for Cancer and Self-Care Support: Results of a Multicenter Randomized TrialJournal of Clinical Oncology, 2014
- A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic settingBMC Health Services Research, 2013
- Improving patient outcomes through the routine use of patient‐reported data in cancer clinics: future directionsPsycho‐Oncology, 2009